FindTrial
Sign In

Comparison of postoperative analgesia of wound site infiltration with bupivacaine and ropivacaine

Postoperative Analgesic Effect of Wound Site Infiltration with Bupivacaine versus Ropivacaine: A Randomised Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021943
Enrollment
60
Registered
2019-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: wound site infiltration with injection bupivacaine: Injection bupivacaine 0.2% at amount of 1ml/cm over 1-2minutes Control Intervention1: wound site infiltration with injection ropivaca

Sponsors

VIMSAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients posted for routine surgeries under general anaesthesia 2.ASAgrade I and II.

Exclusion criteria

Exclusion criteria: 1.Patients with history of allergy to local anaesthetics 2.Pregnant women and lactating mothers 3.Patients with bleeding disorders 4.Patients with psychiatric disorders 5.Patients with neuromuscular disorders

Design outcomes

Primary

MeasureTime frame
Time duration till requirement of first dose of rescue analgesia in cases of infiltration of wound site by ropivacaine,bupivacaineTimepoint: Hours and minutes—

Secondary

MeasureTime frame
Adverse eventsTimepoint: within 10hr of wound site infiltration;Pain will be evaluated by VASTimepoint: at 1,2,4,6,10hr after the wound site infiltration—

Countries

India

Contacts

Public ContactDr Ananta Narayan Patra

VIMSAR

patelmalaya@gmail.com9937756618

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026